Medisinsk forskning på cannabis
I dette arkivet finner du over 15 000 lenker til forskningsartikler og studier på cannabis planten. Listen er på engelsk, delt opp i medisinske lidelser og andre kategorier i alfabetisk rekkefølge.
NB! Sidene på hver bokstav kan laste tregt da tusenvis av linker lastes
S
SAFETY AS A MEDICINE (103)
-
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant for administration by ingestion or other means (Health Canada)
-
Drug Harms in the UK
-
Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use
-
Ocular Hypotensive Efficacy and Safety of Oral Palmytoilethanolamide (Visimast®): Clinical Study
-
Harms associated with psychoactive substances: findings of the UK National Drug Survey
-
A summary of the health harms of drugs â Section 5 Cannabis
-
Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent
-
Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent
-
Role of Cannabinoids in Multiple Sclerosis (link to PDF â
-
Cannabinoid effects on ventilation and breathlessness: A pilot study of efficacy and safety (link to
-
Annual Causes of Death in the United States
-
Prescribing Cannabis for Harm Reduction
-
Medical Marijuana: Clearing Away the Smoke
-
Synthetic cannabinoid and marijuana exposures reported to poison centers
-
Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers
-
Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough?
-
Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users
-
The pharmacologic and clinical effects of medical cannabis
-
Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Î9-THC: Mechanism underlying greater toxicity?
-
Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Î9-THC: Mechanism underlying greater toxicity?
-
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review
-
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review
-
(Re)introducing medicinal cannabis
-
Anticipated Medical Effects on Children From Legalization of Marijuana in Colorado and Washington State
-
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain
-
Physical harm due to chronic substance use
-
Prescribing smoked cannabis for chronic noncancer pain: Preliminary recommendations
-
Physicians as gatekeepers in the use of medical marijuana
-
The Legalization of Marijuana in Colorado: The Impact. Rocky Mountain HIDTA. The Impact
-
A new method of cannabis ingestion: The dangers of dabs?
-
Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice
-
Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: A randomized controlled trial
-
Re-branding cannabis: the next generation of chronic pain medicine?
-
THE EFFECT OF EPIDIOLEX (CANNABIDIOL) ON SERUM LEVELS OF CONCOMITANT ANTI-EPILEPTIC DRUGS IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY IN AN EXPANDED ACCESS PROGRAM
-
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach
-
The cannabis conundrum: Thinking outside the THC box
-
Notes from the Field: Death Following Ingestion of an Edible Marijuana Product-Colorado, March
-
Cannabis and Cannabinoidsâfor health professionals (PDQ®)
-
Cannabis and Cannabinoids (PDQ®): Patient Version
-
Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development
-
Mull it over: cannabis vaporizers and harm reduction
-
No smoke, no fire: What the initial literature suggests regarding vapourized cannabis and respiratory risk
-
Cannabinoids in the management of chronic pain: a front line clinical perspective
-
Perceived risk of regular cannabis use in the United States from 2002 to 2012: Differences by sex, age, and race/ethnicity
-
Cannabis Allergy: What do We Know Anno
-
Cannabis Allergy: What do We Know Anno
-
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis
-
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis
-
Responsible and controlled use: Older cannabis users and harm reduction
-
Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia
-
Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9- tetrahydrocannabinol in older persons with dementia
-
European rating of drug harms
-
Marijuana: A Time-Honored but Untested Treatment for Epilepsy
-
Phytocannabinoids and epilepsy
-
Cannabinoids and Epilepsy
-
Safety of oral dronabinol during opioid withdrawal in humans
-
Safety of oral dronabinol during opioid withdrawal in humans
-
Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample
-
Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample
-
Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS)
-
Half-Baked â The Retail Promotion of Marijuana Edibles
-
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drugâs harm to children and adults, but the scientific evidence is seldom clear-cut
-
How beneficial is vaping cannabis to respiratory health compared to smoking?
-
Peaceful feeling, or up in smoke? Medical marijuana in medicolegal context
-
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products (letter-
-
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
-
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials
-
A safer alternative: Cannabis substitution as harm reduction
-
Efficacy and safety of nabiximols (Sativex®) on multiple sclerosis spasticity in a real-life Italian monocentric study
-
Prescribing medical cannabis in Canada: Are we being too cautious?
-
Merck Manual â Marijuana (Cannabis) Professional version
-
Merck Manual â Marijuana (Cannabis) Consumer version
-
Cannabinoids for pediatric epilepsy? Up in smoke or real science?
-
AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers.
-
Functional selectivity of CB2 cannabinoid receptor ligands at a canonical and noncanonical pathway.
-
CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience
-
CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience
-
Is the medical use of cannabis a therapeutic option for children?
-
Minimal Physical Health Risk Associated With Long-term Cannabis UseâBut Buyer Beware
-
Associations Between Cannabis Use and Physical Health Problems in Early Midlife
-
Drug vaping applied to cannabis: Is âCannavapingâ a therapeutic alternative to marijuana?
-
Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes
-
Cannabinoid Buccal Spray for Chronic Non-Cancer or Neuropathic Pain: A Review of Clinical Effectiveness, Safety, and Guidelines
-
Marijuana â How Safe is it Really?
-
Medical cannabis use in Canada: vapourization and modes of delivery
-
Minnesota Pharmacists and Medical Cannabis: A Survey of Knowledge, Concerns, and Interest Prior to Program Launch
-
Cannabis and Cannabinoids (PDQ®)Health Professional Version
-
Evidence for Medicinal Use of Cannabis
-
Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study
-
Marijuana: Medical Applications, Recreational Use and Substance Abuse Disorders
-
Chapter 5 â Quality Control and Stability Assessment
-
Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain : A systematic review of randomized controlled studies. (scroll down for English version)
-
Plant-Derived and Endogenous Cannabinoids in Epilepsy
-
Comparison of outcome expectancies for synthetic cannabinoids and botanical marijuana.
-
Cannabinoids: Medical implications.
-
Cannabis â Position Paper of the German Respiratory Society (DGP)
-
The Effect of Medicinal Cannabis on Pain and Quality of Life Outcomes in Chronic Pain: A Prospective Open-label Study
-
Qualitative research in Spanish cannabis social clubs: âThe moment you enter the door, you are minimising the risksâ
-
Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms A Mile High
-
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review
-
State of the evidence: Cannabinoids and cancer pain-A systematic review
-
Alcohol and cannabis: Comparing their adverse health effects and regulatory regimes
-
Rocky Mountain High: Preventing Cannabis-Related Injuries
SAFETY-ADULTERANTS/CONTAMINANTS (25)
-
CUT, A Guide to the Adulterants, Bulking agents and other Contaminants found in illicit drugs
-
Too many mouldy joints â marijuana and chronic pulmonary aspergillosis
-
Fatal alveolar haemorrhage following a âbangâ of cannabis
-
Talcum induced pneumoconiosis following inhalation of adulterated marijuana, a case report
-
Determination of pesticide residues in cannabis smoke
-
Hemoptysis in a young man smoking cannabis
-
Potential exposures associated with indoor marijuana growing operations
-
Recurrent myopericarditis as a complication of Marijuana use
-
Inhaled medicinal cannabis and the immunocompromised patient
-
Determination of Herbicides Paraquat, Glyphosate, and Aminomethylphosphonic Acid in Marijuana Samples by Capillary Electrophoresis
-
Cannabis, Pesticides and Conflicting Laws: the Dilemma for Legalized States and Implications for Public Health
-
Levels of selected metals in leaves of Cannabis sativa L. cultivated in Ethiopia
-
Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing
-
Dabble With Danger: A Case Of Severe Respiratory Failure Following Inhalation Of Butane Hash Oil
-
False hashish without cannabis resin
-
Phytoaccumulation of Heavy Metals in Natural Vegetation at the Municipal Wastewater Site in Abbottabad, Pakistan
-
Evaluating the Effects of Gamma-Irradiation for Decontamination of Medicinal Cannabis
-
Drug vaping applied to cannabis: Is âCannavapingâ a therapeutic alternative to marijuana?
-
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues
-
Metagenomic analysis of medicinal Cannabis samples, pathogenic bacteria, toxigenic fungi, and beneficial microbes grow in culture-based yeast and mold tests
-
Analysis of a commerical marijuana e-cigarette formulation
-
Acute intoxication of four individuals following use of the synthetic cannabinoid MABCHMINACA
-
Alveolar haemorrhage following a cannabis water pipe
-
Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA
-
Thermolytic degradation of synthetic cannabinoids: chemical exposures and pharmacological consequences (link to
SCHISTOSOMA INFECTION (2)
SCHIZOPHRENIA/MENTAL DISORDERS (244)
-
Mixed mood disorder
-
Harm Reduction: Alcohol Use Disorder, Cannabis-induced Psychotic Disorder and a tale of two Hemp Oils, in a Patient diagnosed with a Cluster A & B Personality Disorders in Long Term Behavior Therapy
-
Do patients think cannabis causes schizophrenia? â A qualitative study on the causal beliefs of cannabis using patients with schizophrenia
-
Reasons for illicit drug use in people with schizophrenia: Qualitative study
-
Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia
-
Therapeutical use of the cannabinoids in psychiatry
-
A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia
-
CannabinoidâDopamine Interaction in the Pathophysiology and Treatment of CNS Disorders
-
A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice
-
The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample
-
Alterations in Metabotropic Glutamate Receptor 1a and Regulator of G Protein Signaling 4 in the Prefrontal Cortex in Schizophrenia
-
Does intravenous {triangleup}9-tetrahydrocannabinol increase dopamine release? A SPET study
-
Endocannabinoids and Schizophrenia
-
Endocannabinoids and psychiatric disorders: the road ahead
-
Bad Mojo: use of the new marijuana substitute leads to more and more ED visits for acute psychosis
-
Tardive Dystonia and the Use of Cannabis (letter-forum repost-
-
Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats
-
Brain cannabinoid CB2 receptor in schizophrenia
-
Attraction to cannabis among men with schizophrenia: a phenomenological study
-
Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
-
Cannabinoids for the Treatment of Schizophrenia? A Balanced Neurochemical Framework for Both Adverse and Therapeutic Effects of Cannabis Use
-
Gadolinium-HU-308-incorporated micelles
-
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
-
Cannabis, COMT and psychotic experiences
-
Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects
-
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors
-
Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study
-
Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia
-
Cannabis with high cannabidiol content is associated with fewer psychotic experiences
-
Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation?
-
The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids
-
Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
-
The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives
-
Cannabis use predicts shorter duration of untreated psychosis and lower levels of negative symptoms in first-episode psychosis: a South African study
-
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability
-
Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia
-
Synthetic cannabinoid JWH-018 and psychosis: An explorative study
-
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions
-
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Figure 1: n-3/n-6 PUFA dietary imbalance alters PUFAs level in mouse brain
-
Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency
-
Endocannabinoid system dysfunction in mood and related disorders
-
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
-
Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential
-
Prospective Study of Cannabis Use in Adolescents at Clinical High-Risk for Psychosis: Impact on Conversion to Psychosis and Functional Outcome
-
Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong
-
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
-
Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice
-
Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the âMirror Effectâ of Schizophrenia
-
Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts
-
Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders
-
A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotionalâmotivational reactivity
-
The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription
-
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
-
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
-
Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia
-
Cannabinoid modulation of noradrenergic circuits: Implications for psychiatric disorders
-
Cortical basket cell dysfunction in schizophrenia
-
The endocannabinoid system and its role in schizophrenia: a systematic review of the literature
-
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
-
Genetic Variation Underlying Psychosis-inducing Effects of Cannabis: Critical Review and Future Directions (link to PDF â
-
The Yin and Yang of Cannabis-induced Psychosis: the Actions of Î 9-Tetrahydro-cannabinol and Cannabidiol in Rodent Models of Schizophrenia
-
A critical review of the antipsychotic effects of Cannabidiol: 30 years of a translational investigation
-
A critical review of the antipsychotic effects of Cannabidiol: 30 years of a translational investigation.
-
Medical use of cannabis. Cannabidiol: A new light for schizophrenia?
-
Increased gray matter density in patients with schizophrenia and cannabis use: A voxel based morphometric study using DARTEL
-
Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia
-
Neurocognitive functioning and cannabis use in schizophrenia
-
Anandamide dysfunction in prodromal and established psychosis
-
Subjective and Physiological Effects of Oromucosal Sprays Containing Cannabinoids (Nabiximols): Potentials and Limitations for Psychosis Research
-
Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice
-
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia
-
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users
-
Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population
-
Cannabis and psychosis: what causes what?
-
Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission Associated with Olanzapine-Induced Weight Gain
-
An investigation into âtwo hitâ effects of BDNF deficiency and young-adult cannabinoid receptor stimulation on prepulse inhibition regulation and memory in mice
-
The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study
-
âSpiceophreniaâ: a systematic overview of âSpiceâ-related psychopathological issues and a case report
-
Neuregulin-1 Impairs the Long-term Depression of Hippocampal Inhibitory Synapses by Facilitating the Degradation of Endocannabinoid 2-AG
-
Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB1 receptors: implications for schizophrenia
-
What does a mouse tell us about neuregulin 1-cannabis interactions?
-
Peripheral endocannabinoid system dysregulation in first-episode psychosis
-
The role of cannabinoid 1 receptor expressing interneurons in behavior
-
Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes
-
Creativity in cannabis-users and in drug addicts in maintenance treatment and in rehabilitation
-
CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia
-
A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: Potential extinction enhancers
-
Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats
-
Neonatal lipopolysaccharide treatment has long term effects on monoaminergic and cannabinoid receptors in the rat
-
Cigarette smoking and cannabis use are equally strongly associated with psychotic-like experiences: a cross-sectional study in 1929 young adults
-
Psychosis and Severe Rhabdomyolysis Associated with Synthetic Cannabinoid Use
-
Neonatal lipopolysaccharide treatment has long-term effects on monoaminergic and cannabinoid receptors in the rat
-
Electroconvulsive Therapy (ECT) for Catatonia in a Patient With Schizophrenia and Synthetic Cannabinoid Abuse: A Case Report
-
Quantification of endocannabinoids in postmortem brain of schizophrenic subjects
-
Association of Single-Nucleotide Polymorphisms in the Cannabinoid Receptor 2 Gene with Schizophrenia in the Han Chinese Population
-
Effect of reclassification of cannabis on hospital admissions for cannabis psychosis: A time series analysis
-
Cannabis abuse is associated with better emotional memory in schizophrenia: A functional magnetic resonance imaging study
-
Dominant negative DISC1 mutant mice display specific social behaviour deficits and aberration in BDNF and cannabinoid receptor expression
-
Fatty acid ethanolamide levels are altered in borderline personality and complex post-traumatic stress disorders
-
The endocannabinoid system and its possible role in neurobiology of psychiatric disorders
-
Cannabidiol as a potential treatment for psychosis
-
The vital role of constitutive GPCR activity in the mesolimbic dopamine system
-
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuro-psychiatric disorders
-
CB1 cannabinoid receptors are involved in neuroleptic-induced enhancement of brain neurotensin
-
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain
-
Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders
-
A controlled family study of cannabis users with and without psychosis
-
Impaired Fear Memory Specificity Associated with Deficient Endocannabinoid Dependent Long-Term Plasticity
-
Cannabinoid Transmission in the Prefrontal Cortex Bi-Phasically Controls Emotional Memory Formation via Functional Interactions with the Ventral Tegmental Area
-
Acute administration of Î9 tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice
-
Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia
-
Genetic predisposition to schizophrenia associated with increased use of cannabis
-
Paranoid Personality Disorder in the United States: The Role of Race, Illicit Drug Use, and Income
-
Increasing Endocannabinoid Levels in the Ventral Pallidum Restore Aberrant Dopamine Neuron Activity in the Subchronic PCP Rodent Model of Schizophrenia
-
Smoking synthetic marijuana leads to self-mutilation requiring bilateral amputations
-
Risk-taking in schizophrenia and controls with and without cannabis dependence
-
Hippocampal Cannabinoid Transmission Modulates Dopamine Neuron Activity: Impact on Rewarding Memory Formation and Social Interaction
-
Cannabis use and suicidal ideations in high-school students
-
Cannabis Use and its Effects on Health, Education and Labor Market Success
-
Cannabinoids and schizophrenia: therapeutic prospects
-
Anandamide attenuates haloperidol-induced vacuous chewing movements in rats
-
Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia
-
Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population
-
Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed
-
Cannabinoids reward sensitivity in a neurodevelopmental animal model of schizophrenia: A brain stimulation reward study
-
Use of Synthetic Cannabinoids in Patients With Psychotic Disorders: Case Series
-
The influence of personality on the sensitivity to subjective effects of Î9-tetrahydro-cannabinol
-
Developmentally vitamin D-deficient rats show enhanced prepulse inhibition after acute Î9-tetrahydrocannabinol
-
Impact of Cannabis Use on the Development of Psychotic Disorders
-
Synthetic cannabis-induced mania
-
Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice
-
Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice
-
Cannabis and psychopathology: The meandering journey of the last decade
-
Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis
-
A clinical comparison of schizophrenia with and without pre-onset cannabis use disorder: a retrospective cohort study using categorical and dimensional approaches
-
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men
-
Cannabinoids for Medical Use A Systematic Review and Meta-analysis
-
Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory
-
Cannabis abuse effects on prepulse inhibition in patients with first episode psychosis in schizophrenia
-
Further human evidence for striatal dopamine release induced by administration of â9-tetrahydrocannabinol (THC): selectivity to limbic striatum
-
Further human evidence for striatal dopamine release induced by administration of Î9- tetrahydrocannabinol (THC): selectivity to limbic striatum
-
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample
-
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample
-
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior
-
The phytocannabinoid, Î(9) -tetrahydrocannabivarin, can act through 5-HT1 A receptors to produce antipsychotic effects
-
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects
-
Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Î9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences
-
β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling
-
β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling
-
Cannabis conundrum : Evidence of harm? : Opposition to marijuana use is often rooted in arguments about the drugâs harm to children and adults, but the scientific evidence is seldom clear-cut
-
Marijuana, Reconsidered: Dr. Lester Grinspoon On 45 Years Of Cannabis Science (interview-
-
Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol
-
A systematic review of the antipsychotic properties of cannabidiol in humans
-
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders
-
Association of single nucleotide polymorphisms in catechol-O-methyltransferase and serine-threonine protein kinase genes in the Pakistani schizophrenic population: a study with special emphasis on cannabis and smokeless tobacco
-
Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine
-
Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms
-
Catatonia and Cannabis Withdrawal: a case report
-
No additive effect of cannabis on cognition in schizophrenia
-
Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids
-
Endocannabinoids and Mental Disorders
-
Reduced Brain Cannabinoid Receptor Availability In Schizophrenia
-
The CCDC55 couples cannabinoid receptor CNR1 to a putative DISC1 schizophrenia pathway
-
Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis
-
Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long-term potentiation in the mouse hippocampus
-
Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience
-
An Introduction to the Endogenous Cannabinoid System
-
Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: Possible involvement of the endocannabinoid system
-
Cannabidiol and sodium nitroprusside: two novel neuromodulatory pharmacological interventions to treat and prevent psychosis
-
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory
-
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia
-
AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers
-
A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder
-
ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice
-
Synthetic Cannabinoid Receptor Agonist-Associated Psychotic Disorder: A Case Report
-
Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction
-
First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone
-
Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
-
Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial
-
Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History
-
Endocannabinoid signaling in social functioning: an RDoC perspective
-
Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy
-
Synthetic Cannabis Overdose and Withdrawal in a Young Adult: A Case Report, Commentary on Regulation, and Review of the Literature
-
Assessing causality in associations between cannabis use and schizophrenia risk: a twosample Mendelian randomization study
-
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis
-
Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway
-
Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis
-
Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients
-
Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release
-
Salience attribution and its relationship to cannabis-induced psychotic symptoms
-
Violence and self-harm in severe mental illness: inpatient study of associations with ethnicity, cannabis and alcohol
-
Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced Olfactory Discrimination Deficit (click âFull Text Linksâ for
-
Suppressing Schizophrenia Symptoms Without Side Effects: Mouse Study
-
Lipids in psychiatric disorders and preventive medicine
-
Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis
-
Cannabis and Psychosis: a Critical Overview of the Relationship
-
The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders
-
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia
-
A Case of Butane Hash Oil (Marijuana Wax)-Induced Psychosis
-
Cannabinoids for the Treatment of Schizophrenia: An Overview
-
Cannabis-induced psychosis associated with high potency âwax dabsâ
-
Cannabidiol, neuroprotection and neuropsychiatric disorders
-
Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis
-
Effects of the antipsychotic paliperidone on stress-induced changes in the endocannabinoid system in rat prefrontal cortex
-
Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder
-
Acute Psychosis after Consumption of Synthetic Cannabinoids
-
Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use
-
Distinct neuronal activation patterns are associated with PCP-induced social withdrawal and its reversal by the endocannabinoid-enhancing drug URB597
-
Association between schizotypal and borderline personality disorder traits, and cannabis use in young adults
-
A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis
-
Positron Emission Tomography Studies on Cannabinoid Receptor Type 1 in Schizophrenia
-
Could cannabidiol be used as an alternative to antipsychotics?
-
Cannabis and Alcohol Use, Affect, and Impulsivity in Psychiatric Outpatientsâ Daily Lives
-
Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia
-
Characteristics of Synthetic Cannabinoid and Cannabis Users Admitted to a Psychiatric Hospital: A Comparative Study
-
Does cannabidiol have a role in the treatment of schizophrenia?
-
Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment
-
Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophrenia
-
Cannabis and a lower BMI in psychosis: What is the role of AKT1?
-
Cannabinoids and Psychosis (3)
-
Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia
-
Abnormal white matter integrity in synthetic cannabinoid users
-
Seeing through the smoke: human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks
-
Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia
-
Cannabinoids: Glutamatergic Transmission and Kynurenines
-
Drug Dependence and Toxicity of Law-Evading Drugs: Their Mechanisms Explored from Basic Research
-
The Effects of Cannabis on Inpatient Agitation, Aggression, and Length of Stay
-
Association of Anandamide with altered Binocular Depth Inversion Illusion in Schizophrenia
-
Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia
-
Characteristics associated with synthetic cannabinoid use among patients treated in a public psychiatric emergency setting
-
Pros and cons of medical cannabis use by people with chronic brain disorders
-
Targeting the Endocannabinoid System in Psychiatric Illness
-
Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence
-
The effects of cannabis use on salience attribution: a systematic review
-
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia
-
The consequences of chronic cannabis smoking in vulnerable adolescents
-
Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: Evidence for defective immunomodulatory mechanisms
-
Motivational changes of cannabis use prior to and during the course of schizophrenia
-
Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls
-
The role of the CNR1 gene in schizophrenia: a systematic review including unpublished data
-
The Impact of CB2 Receptor Ligands on the MK-801-Induced Hyperactivity in Mice
-
Short communication: Genetic association between schizophrenia and cannabis use
-
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia
-
Cannabis use, COMT, BDNF and age at first-episode psychosis
SCLERODERMA (11)
-
Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis
-
Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis
-
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
-
The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model
-
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis
-
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system
-
Pathogenesis of Systemic Sclerosis
-
The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways
-
Can Cannabinoids Modulate Fibrotic Progression in Systemic Sclerosis?
-
Cannabinoids and autoimmune diseases: A systematic review
-
Cannabinoids, inflammation, and fibrosis
SEBACEOUS GLANDS (6)
-
âSebocytesâ makeupâ: novel mechanisms and concepts in the physiology of the human sebaceous glands
-
TRP channel cannabinoid receptors in skin sensation, homeostasis, and inflammation
-
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes
-
The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content
-
Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrheic skin and acne treatment
-
Targeting Cutaneous Cannabinoid Signaling in Inflammation â A âHighâ-way to Heal?
SEPTIC SHOCK/SEPSIS (21)
-
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
-
Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture
-
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study
-
The endocannabinoid system in sepsis â a potential target to improve microcirculation?
-
Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation
-
Cannabinoids and sepsis
-
Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis
-
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
-
Cannabinoid Receptor 2 Protects against Acute Experimental Sepsis in Mice
-
Cytokine release in sepsis
-
Targeting the Endocannabinoid System to Treat Sepsis
-
Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gut
-
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis
-
Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections
-
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells
-
Novel approaches to the development of anti-sepsis drugs
-
New horizons for newborn brain protection: enhancing endogenous neuroprotection
-
Î9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells
-
Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusionin the iridial microvasculature during systemic inflammation
-
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
-
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia
SICKLE CELL DISEASE (8)
-
New Era Dawns on Sickle Cell Pain
-
Pain related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids
-
Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness
-
Traditional Herbal Management of Sickle Cell Anemia: Lessons from Nigeria
-
Priapism in a patient with sickle cell trait using marijuana
-
Cannabinoid receptor-specific mechanisms to ameliorate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation
-
Quantification of pain in sickle mice using facial expressions and body measurements
-
Sickle Cell Crisis Complicated by Synthetic Cannabinoid Abuse: A Case Report
SLEEP APNEA (12)
-
Circulating endocannainoids and N-acyl-ethanolamides in patients with sleep apnea â specific role of oleoylethanolamide
-
A study on the endogenous cannabinoid system synthetic and catabolic enzyme levels in patients with obstructive sleep apnea
-
Circulating anandamide and blood pressure in patients with obstructive sleep apnea
-
Proof of concept trial of dronabinol in obstructive sleep apnea
-
Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat
-
Identification of a Pharmacological Target for Genioglossus Reactivation throughout Sleep
-
Impact of dronabinol on quantitative electroencephalogram (qEEG) measures of sleep in obstructive sleep apnea syndrome
-
Cannabinoid Type 1 and Type 2 Receptor Antagonists Prevent Attenuation of Serotonin Induced Reflex Apneas by Dronabinol in Sprague-Dawley Rats
-
Cannabinoid Type 1 Receptor Antagonist, AM251, Prevents Attenuation Of Serotonin induced Apneas By Dronabinol In Sprague-Dawley Rats
-
Emerging Drugs for Common Conditions of Sleepiness: Obstructive Sleep Apnea and Narcolepsy
-
Circulating Endocannabinoids and Insulin Resistance in Patients with Obstructive Sleep Apnea
-
Intracerebroventricular injections of dronabinol, a cannabinoid receptor agonist, does not attenuate serotonin-induced apnea in Sprague-Dawley rats
SLEEP MODULATION (89)
-
Mixed mood disorder
-
Marijuana helps narcolepsy
-
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
-
The Maternal Lifestyle Study: Sleep Problems in Children with Prenatal Substance Exposure
-
The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial
-
Endocannabinoid signalling: has it got rhythm?
-
Sleep and Medicinal Cannabis
-
Oleoylethanolamide affects food intake and sleep-waking cycle through a hypothalamic modulation
-
Acute and subchronic administration of anandamide or oleamide increases REM sleep in rats
-
Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats
-
A Pilot Study into the Effects of the CB1 Cannabinoid Receptor Agonist WIN55,212-2 or the Antagonist/Inverse Agonist AM251 on Sleep in Rats
-
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial
-
Characterizing smoking topography of cannabis in heavy users
-
Role of Cannabinoids in Multiple Sclerosis
-
Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats
-
Effects on sleep and dopamine levels of microdialysis perfusion of cannabidiol into the lateral hypothalamus of rats
-
The emerging role of the endocannabinoid system in the sleep-wake cycle modulation
-
CADTH Rapid Response Report: Cannabinoids for the treatment of post-traumatic stress disorder
-
Cannabidiol in humans-the quest for therapeutic targets
-
Neuromodulators for pain management in rheumatoid arthritis
-
Oleamide restores sleep in adult rats that were subjected to maternal separation
-
A Randomized, Double-Blind, Placebo Controlled, Parallel Assignment, Flexible Dose, Efficacy Study of Nabilone as Adjuvant in the Treatment of Diabetic Peripheral Neuropathic Pain Using an Enriched Enrollment Randomized Withdrawal Design (S38.003)
-
Using cannabis to help you sleep: Heightened frequency of medical cannabis use among those with PTSD
-
Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers
-
Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats
-
Entopeduncular nucleus endocannabinoid system modulates sleep-waking cycle and mood in rats
-
2-AG into the lateral hypothalamus increases REM sleep and cFos expression in melanin concentrating hormone neurons in rats
-
Cardiorespiratory control as a function of wake-sleep behavior and diet in mice lacking CB1 cannabinoid receptors
-
The administration of endocannabinoid uptake inhibitors OMDM-2 or VDM-11 promotes sleep and decreases extracellular levels of dopamine in rats
-
Sleep Quality Moderates the Relation between Depression Symptoms and Problematic Cannabis Use among Medical Cannabis Users
-
The impact of perceived sleep quality and sleep efficiency/duration on cannabis use during a self-guided quit attempt
-
Poor sleep quality as a risk factor for lapse following a cannabis quit attempt
-
Endocannabinoid Modulation of Cortical Up-States and NREM Sleep
-
Multiple sleep alterations in mice lacking cannabinoid type 1 receptors
-
Impact of dronabinol on quantitative electroencephalogram (qEEG) measures of sleep in obstructive sleep apnea syndrome
-
Cardiorespiratory Anomalies in Mice Lacking CB1 Cannabinoid Receptors
-
Therapeutic benefits of cannabis: a patient survey
-
Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review
-
Use of a Synthetic Cannabinoid in a Correctional Population for Posttraumatic Stress Disorder-Related Insomnia and Nightmares, Chronic Pain, Harm Reduction, and Other Indications: A Retrospective Evaluation
-
Potential effects of cannabidiol as a wake-promoting agent
-
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment
-
Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review
-
Anandamide activation of CB1 receptors increases spontaneous bursting and oscillatory activity in the thalamus
-
Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats
-
Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinsonâs disease patients: a case series
-
Inhibition of diacylglycerol lipase (DAGL) in the lateral hypothalamus of rats prevents the increase in REMS and food ingestion induced by PAR1 stimulation
-
Endocannabinoid signaling modulates neurons of the pedunculopontine nucleus (PPN) via astrocytes
-
When time stands still: an integrative review on the role of chronodisruption in posttraumatic stress disorder
-
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users
-
2-Arachidonoylglycerol into the lateral hypothalamus improves reduced sleep in adult rats subjected to maternal separation
-
INVESTIGATING SEDATIVE, PREANAESTHETIC & ANTI-ANXIETY EFFECTS OF HERBAL EXTRACT OF CANNABIS SATIVA IN COMPARISON WITH DIAZEPAM IN RATS
-
Cannabis Withdrawal Among Detained Adolescents: Exploring the Impact of Nicotine and Race
-
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study
-
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study
-
Cannabis and Cannabinoidsâfor health professionals (PDQ®)
-
Cannabis and Cannabinoids (PDQ®): Patient Version
-
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup
-
Cannabinoids for Medical Use A Systematic Review and Meta-analysis
-
Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-arachidonoylglycerol
-
Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-arachidonoylglycerol
-
The effects of chronic marijuana use on circadian entrainment
-
Cannabis withdrawal and sleep: A systematic review of human studies
-
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome
-
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials
-
Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users
-
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children
-
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder
-
Rhythmic control of endocannabinoids in the rat pineal gland
-
Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users
-
Endocannabinoid Signaling Regulates Sleep Stability
-
Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans
-
The impact of drugs for multiple sclerosis on sleep
-
Cannabis and Cannabinoids (PDQ®)Health Professional Version
-
Marijuana Compounds: A Nonconventional Approach to Parkinsonâs Disease Therapy
-
Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study
-
Dose-dependent cannabis use, depressive symptoms, and FAAH genotype predict sleep quality in emerging adults: a pilot study
-
Direct presynaptic and indirect astrocyte-mediated mechanisms both contribute to endocannabinoid signaling in the pedunculopontine nucleus of mice
-
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity
-
Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment
-
Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention
-
Marijuana use in adults admitted to a Canadian epilepsy monitoring unit
-
Contribution of health motive to cannabis use among high-school students
-
Disturbances of sleep and circadian rhythms: novel risk factors for obesity
-
Importance of Urinary Drug Screening in the Multiple Sleep Latency Test and Maintenance of Wakefulness Test
-
The hazards of bad sleep-Sleep duration and quality as predictors of adolescent alcohol and cannabis use
-
Revealing the role of the endocannabinoid system modulators, SR141716A, URB597 and VDM-11, in sleep homeostasis
-
Endocannabinoids and sleep
-
Regulation of fear extinction by long-term depression: the roles of endocannabinoids and brain derived neurotrophic factor
-
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis
SLEEPING SICKNESS / TRYPANOSOMIASIS (1)
SMELL/ODOR DETECTION (25)
-
The endocannabinoid 2-arachidonoyl-glycerol controls odor sensitivity in larvae of Xenopus laevis
-
Cannabinoids increase conditioned ultrasonic vocalisations and cat odour avoidance in rats: strain differences in drug-induced anxiety
-
Endocannabinoid modulation in the olfactory epithelium
-
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial
-
Acute Immobilization Stress Modulate GABA Release from Rat Olfactory Bulb: Involvement of Endocannabinoids-Cannabinoids and Acute Stress Modulate GABA Release
-
Cannabinoid receptor-mediated regulation of neuronal activity in the main olfactory bulb
-
Handler beliefs affect scent detection dog outcomes
-
Cannabinoid receptor-mediated regulation of neuronal activity and signaling in glomeruli of the main olfactory bulb
-
G-Protein-Coupled Receptors in Intestinal Chemosensation
-
Sniffing out pharmacology: interactions of drugs with human olfaction
-
Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ
-
Identification of odorant-receptor interactions by global mapping of the human odorome
-
Effects of 20 mg oral Î9 -tetrahydrocannabinol on the olfactory function of healthy volunteers
-
Detecting Cannabis Use on the Human Skin Surface via an Electronic Nose System
-
The endocannabinoid system controls food intake via olfactory processes
-
New insights on food intake control by olfactory processes: the emerging role of the endocannabinoid system
-
Cellular Mechanisms of Action of Drug Abuse on Olfactory Neurons
-
An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction
-
A state-of-the-art review of the management and treatment of taste and smell alterations in adult oncology patients
-
A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women
-
Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid
-
Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced Olfactory Discrimination Deficit. (click âFull Text Linksâ for
-
Rational Basis for the Use of Bergamot Essential Oil in Complementary Medicine to Treat Chronic Pain
-
Effects of analgesics on olfactory function and the perception of intranasal trigeminal stimuli
-
Cannabinoid receptor signaling induces proliferation but not neurogenesis in the mouse olfactory epithelium
SMOKED CANNABIS AS A MEDICATION (86)
-
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
-
Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study
-
Canadian Ophthalmological Society policy statement on the medical use of marijuana for glaucoma
-
The relationship between substance use and posttraumatic stress disorder in a methadone maintenance treatment program
-
Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas-possible role of Cannabis inhalation
-
Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life
-
Posttraumatic Stress and Marijuana Use Coping Motives: The Mediating Role of Distress Tolerance
-
Medical cannabis use in post-traumatic stress disorder: a naturalistic observational study
-
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
-
Association of herbal cannabis use with negative psychosocial parameters in patients with fibromyalgia
-
Use of cannabis among 139 cluster headache sufferers
-
Role of Cannabinoids in Multiple Sclerosis
-
Seizure exacerbation in two patients with focal epilepsy following marijuana cessation
-
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis
-
The impact of marijuana use on glucose, insulin, and insulin resistance among US adults
-
Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV-Hepatitis C Coinfection: A Longitudinal Cohort Analysis
-
Towards a better Cannabis drug
-
Cannabis and other illicit drug use in epilepsy patients
-
The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS
-
Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study
-
Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120
-
Cannabis Induces a Clinical Response in Patients with Crohnâs Disease: a Prospective Placebo-Controlled Study
-
Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana In Daily Marijuana Smokers
-
Medical Marijuana Coverage Still Lost in the Legal Weeds
-
Medicinal Cannabis and Painful Sensory Neuropathy
-
Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice
-
Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample
-
Prescribing smoked cannabis for chronic noncancer pain: Preliminary recommendations
-
Endocannabinoids Control Platelet Activation and Limit Aggregate Formation under Flow
-
Patterns and correlates of cannabis use among individuals with HIV/AIDS in Maritime Canada
-
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters
-
Cannabis smoking and serum C-reactive protein: A quantile regressions approach based on NHANES 2005â2010
-
Inhaled medicinal cannabis and the immunocompromised patient
-
How Smoking Marijuana Might Be The Best Way To Prevent Alzheimerâs Disease
-
Cannabis (Medical Marijuana) Treatment for Motor and Non-Motor Symptoms of Parkinson Disease: An Open-Label Observational Study
-
Marijuana, expectancies, and post-traumatic stress symptoms: a preliminary investigation
-
Effect of Marijuana Use on Outcomes in Traumatic Brain Injury
-
Cannabis, cannabidiol, and epilepsy â From receptors to clinical response
-
Experience of adjunctive cannabis use for chronic non-cancer pain: Findings from the Pain and Opioids IN Treatment (POINT) study
-
The Association Between Normal Optic Nerve Cupping , Normal Visual Fields and Marijuana Use
-
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach
-
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use
-
Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials
-
Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH)
-
Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis
-
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders
-
Self-medication of achalasia with cannabis, complicated by a cannabis use disorder
-
Cannabis abuse effects on prepulse inhibition in patients with first episode psychosis in schizophrenia
-
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience
-
Cannabis Smoking and Diabetes Mellitus: Results from Meta-analysis with Eight Independent Replication Samples
-
Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?
-
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone
-
Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data
-
Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS)
-
Association Between Cannabis Use and the Risk of Bladder Cancer: Results From the California Menâs Health Study
-
Smoke Your Troubles Away: Exploring the Effects of Death Cognitions on Cannabis Craving and Consumption
-
Combined effects of HIV and marijuana use on neurocognitive functioning and immune status
-
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors
-
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis
-
Prescribing medical cannabis in Canada: Are we being too cautious?
-
Being the Victim of Violence during a Date predicts Next-Day Cannabis Use among Female College Students
-
Is cannabis use associated with less opioid use among people who inject drugs?
-
Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population
-
âI Use Weed for My ADHDâ: A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD
-
Joint Effects: A Pilot Investigation of the Impact of Bipolar Disorder and Marijuana Use on Cognitive Function and Mood
-
Integrating cannabis into clinical cancer care
-
Neuropathic Pain Treatment: Still a Challenge
-
Cannabis and Cannabinoids (PDQ®)Health Professional Version
-
Marijuana effects on changes in brain structure and cognitive function among HIV+ and HIV- adults
-
The use of medical-grade cannabis in patients non-responders to Nabiximols
-
Prior Cannabis Use Is Associated with Outcome after Intracerebral Hemorrhage
-
Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain : A systematic review of randomized controlled studies. (scroll down for English version)
-
Plant-Derived and Endogenous Cannabinoids in Epilepsy
-
Cannabinoids: Medical implications
-
Cannabis in Pain Treatment: Clinical & Research Considerations
-
Metabolic syndrome in people with a psychotic illness: is cannabis protective?
-
The Effect of Medicinal Cannabis on Pain and Quality of Life Outcomes in Chronic Pain: A Prospective Open-label Study
-
No significant effect of cannabis use on the count and percentage of circulating CD4 Tcells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort)
-
Associations of Posttraumatic Stress Disorder Symptoms With Marijuana and Synthetic Cannabis Use Among Young Adult U.S. Veterans: A Pilot Investigation
-
Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention
-
Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms A Mile High
-
Contribution of health motive to cannabis use among high-school students
-
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review
-
Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinsonâs disease
-
Effects of Marijuana on ictal and interictal EEG activity in idiopathic generalized epilepsy
-
Survey of herbal cannabis (marijuana) use in rheumatology clinic attenders with a rheumatologist confirmed diagnosis
SOCIAL ADJUSTMENT/BEHAVIOR (149)
-
Sex difference in cell proliferation in developing rat amygdala mediated by endocannabinoids has implications for social behavior
-
Influence of cannabis use trajectories, grade repetition and family background on the school-dropout rate at the age of 17 years in France
-
Preservation of Striatal Cannabinoid CB1 Receptor Function Correlates with the Antianxiety Effects of Fatty Acid Amide Hydrolase Inhibition
-
A Life-course Perspective on the âGateway Hypothesisâ
-
A Sociological Theory of Drug Sales, Gifts, and Frauds
-
Patterns of Youth Participation in Cannabis Cultivation
-
Cannabis and crime: findings from a longitudinal study
-
Gender moderates the impact of stereotype threat on cognitive function in cannabis users
-
Gender differences in adolescent marijuana use and associated psychosocial characteristics
-
Marijuana and Tobacco Use: Examination of Concurrent Associations with Negative Mood States
-
Drug-Intake Methods and Social Identity: The Use of Marijuana in Blunts Among Southeast Asian Adolescents and Emerging Adults
-
Rural Adolescent Alcohol, Tobacco and Illicit Drug Use: A Comparison of Students in Victoria, Australia and Washington State, United States
-
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients
-
The social contagion effect of marijuana use among adolescents
-
Racial differences in trajectories of heavy drinking and regular marijuana use from ages 13 to 24 among African-American and White males
-
The association between early conduct problems and early marijuana use in college students
-
Profile of Psychoactive Substances Consumption in Workplace
-
Alcohol and cannabis abuse/dependence symptoms and life satisfaction in young adulthood
-
High on Life? Medical Marijuana Laws and Suicide
-
Differences in Spontaneously Avoiding or Approaching Mice Reflect Differences in CB1-Mediated Signaling of Dorsal Striatal Transmission
-
Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images
-
Cannabidiol in humans-the quest for therapeutic targets
-
Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice
-
Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats
-
The combined effects of parental divorce and parental history of depression on cannabis use in young adults in France
-
Cannabis Use Vulnerability Among Socially Anxious Users: Cannabis Craving During a Social Interaction
-
âItâs just a social thingâ: Drug use, friendship and borderwork among marginalized young people
-
Identity Formation, Marijuana and âThe Selfâ: A Study of Cannabis Normalization among University Students
-
Fascination and Social Togetherness-Discussions about Spice Smoking on a Swedish Internet Forum
-
Perception of tobacco, cannabis, and alcohol use of others is associated with oneâs own use
-
Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study
-
Do societal wealth, family affluence and gender account for trends in adolescent cannabis use? A 30 country cross-national study
-
Do societal wealth, family affluence and gender account for trends in adolescent cannabis use? A 30 country cross-national study
-
Cannabis Use, Employment, and Income: Fixed-Effects Analysis of Panel Data
-
CB1 receptor signaling regulates social anxiety and memory
-
THE IMPORTANCE OF FAMILY RELATIONS FOR CANNABIS USERS: THE CASE OF SERBIAN ADOLESCENTS
-
Higher rates of adolescent substance use in child welfare versus community populations in the United States
-
Higher rates of adolescent substance use in child welfare versus community populations in the United States
-
The role of child protection in cannabis grow-operations
-
Can Marijuana Reduce Social Pain?
-
From âSocial Supplyâ to âReal Dealingâ: Drift, Friendship, and Trust in Drug-Dealing Careers
-
Identity formation, marijuana and âthe selfâ: a study of cannabis normalization among university students
-
Creativity in cannabis-users and in drug addicts in maintenance treatment and in rehabilitation
-
Illegal drugs and delinquency
-
Adolescent peer-rejection persistently alters pain perception and CB1 receptor expression in female rats
-
CB1 cannabinoid receptor-mediated aggressive behavior
-
Cannabis use motives and personality risk factors
-
Cannabis use in a Swiss male prison: Qualitative study exploring detaineesâ and staffsâ perspectives
-
The Effect of Medical Marijuana Laws on Crime: Evidence from State Panel Data, 1990-2006
-
Genetic Variations in the Human Cannabinoid Receptor Gene Are Associated with Happiness
-
Moderate-Vigorous Physical Activity across Body Mass Index in Females: Moderating Effect of Endocannabinoids and Temperament
-
An Examination of Opinions Toward Marijuana Policies Among High School Seniors in the United States
-
Marijuana Policy in Colorado
-
Early onset of cannabis use: Does personality modify the relation with changes in perceived parental involvement?
-
Acute alcohol use temporally increases the odds of male perpetrated dating violence: A 90-day diary analysis
-
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
-
Prevalence and correlates of alcohol and cannabis use disorders in the United States: Results from the national longitudinal study of adolescent health
-
Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation
-
Couplesâ Marijuana Use Is Inversely Related to Their Intimate Partner Violence Over the First 9 Years of Marriage
-
Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and Anhedonia Induced by LPS in Rats
-
Cannabinoid Modulation of Amygdala Subregion Functional Connectivity to Social Signals of Threat
-
Risk-taking in schizophrenia and controls with and without cannabis dependence
-
Risk-taking in schizophrenia and controls with and without cannabis dependence
-
Hippocampal Cannabinoid Transmission Modulates Dopamine Neuron Activity: Impact on Rewarding Memory Formation and Social Interaction
-
Interpersonal Guilt and Substance Use in College Students
-
Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion
-
Cannabis Use and its Effects on Health, Education and Labor Market Success
-
Strain and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats
-
Role of CNR1 polymorphisms in moderating the effects of psychosocial adversity on impulsivity in adolescents
-
Socialization Instances Linked to Cannabis Experimentation Among French Teenagers
-
The influence of personality on the sensitivity to subjective effects of Î9-tetrahydrocannabinol
-
Frequent electronic media communication with friends is associated with higher adolescent substance use
-
Involvement of 2-arachidonoylglycerol signaling in social challenge responding of male CD1 mice
-
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1âE9 mice
-
Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimerâs disease transgenic mice
-
Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial
-
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors
-
Stigma among Californiaâs Medical Marijuana Patients
-
To Act or Not to Act: Endocannabinoid/Dopamine Interactions in Decision-Making
-
The role of the Cannabinoid Receptor 1 in adolescentsâ processing of facial expressions
-
Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxiety like behavior and sociability
-
Neuropsychological sex differences associated with age of initiated use among young adult cannabis users
-
Neuropsychological sex differences associated with age of initiated use among young adult cannabis users
-
Young adult cannabis users report greater propensity for risk-taking only in non-monetary domains
-
Young adult cannabis users report greater propensity for risk-taking only in non-monetary domains
-
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes
-
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes
-
Reasons for recent marijuana use in relation to use of other illicit drugs among high school seniors in the United States
-
Reasons for recent marijuana use in relation to use of other illicit drugs among high school seniors in the United States
-
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior
-
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior
-
Prevalence of Marijuana-Related Traffic on Twitter, 2012-2013: A Content Analysis
-
Twitter Chatter about Marijuana
-
Social anxiety and cannabis cravings: The influences of parent injunctive norms and tension reduction expectancies
-
Cannabidiol as a Potential Treatment for Anxiety Disorders
-
Effects of amphetamine, morphine, and CP 55,â940 on Go/No-Go task performance in rhesus monkeys
-
Role of CB2 receptors in social and aggressive behavior in male mice
-
From substance use to homelessness or vice versa?
-
Use and effects of cannabinoids in military veterans with post-traumatic stress disorder
-
Antidepressant-like activity and cardioprotective effects of fatty acid amide hydrolase inhibitor URB694 in socially stressed Wistar Kyoto rats
-
Maternal separation and early stress cause long-lasting effects on dopaminergic and endocannabinergic systems and alters dendritic morphology in the nucleus accumbens and frontal cortex in rats
-
Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: Possible involvement of the endocannabinoid system
-
Who receives cannabis use offers: A general population study of adolescents
-
The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus
-
Natural outcome of cannabis use disorder: a 3-year longitudinal follow-up
-
Being the Victim of Violence during a Date predicts Next-Day Cannabis Use among Female College Students
-
Investigating cannabis use normalization by distinguishing between experimental and regular use: a multilevel study in 31 countries
-
Difficulties in emotion regulation are associated with panic symptom severity following a quit attempt among cannabis dependent veterans
-
Dissociating the role of endocannabinoids in the pleasurable and motivational properties of social play behaviour in rats
-
Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction
-
Effects of various cannabinoid ligands on choice behaviour in a rat model of gambling
-
Endocannabinoid signaling in social functioning: an RDoC perspective
-
Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid
-
Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling
-
Interacting Cannabinoid and Opioid Receptors in the Nucleus Accumbens Core Control Adolescent Social Play
-
Solitary cannabis use frequency mediates the relationship between social anxiety and cannabis use and related problems
-
Assessment of rates of recanting and hair testing as a biological measure of drug use in a general population sample of young people
-
Lifelong imbalanced linoleic/alpha-linolenic acid intake impairs emotional and cognitive behavior in adult rats via changes in brain endocannabinoid system (click âFull Text Linksâ to
-
The Effect of Medical Marijuana on Sickness Absence
-
Lipids in psychiatric disorders and preventive medicine
-
A Genetic Component to National Differences in Happiness
-
Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication
-
From âherbal highsâ to the âheroin of cannabisâ: Exploring the evolving discourse on synthetic cannabinoid use in a Norwegian Internet drug forum
-
Social defeat leads to changes in the endocannabinoid system, an overexpression of calreticulin and motor impairment in mice
-
A role for the endocannabinoid 2-arachidonoyl-sn-glycerol for social and high-fat food reward in male mice.
-
Distinct neuronal activation patterns are associated with PCP-induced social withdrawal and its reversal by the endocannabinoid-enhancing drug URB597
-
Adolescent social rejection alters pain processing in a CB1 receptor dependent manner.
-
Social Anxiety and Cannabis-Related Impairment: The Synergistic Influences of Peer and Parent Descriptive and Injunctive Normative Perceptions
-
Neural endocannabinoid CB1 receptor expression, social status, and behavior in male European starlings
-
Neural mechanisms of sensitivity to peer information in young adult cannabis users
-
Declining Prevalence of Marijuana Use Disorders Among Adolescents in the United States, 2002 to
-
Cannabis and Alcohol Use, Affect, and Impulsivity in Psychiatric Outpatientsâ Daily Lives.
-
Traffic accidentability and risky driving behavior in young people in New Caledonia. of study
-
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling.
-
The neurobiology of social play and its rewarding value in rats.
-
Risky substance use and peer pressure in Swiss young men: Test of moderation effects.
-
Restricted vs. unrestricted wheel running in mice: Effects on brain, behavior and endocannabinoids.
-
UPPS-P model impulsivity and marijuana use behaviors in adolescents: A meta-analysis
-
Changing perspectives on marijuana use during early adolescence and young adulthood: Evidence from a panel of cross-sectional surveys.
-
The neurobiology of social play and its rewarding value in rats
-
Determining Cannabis Use Status From a Photograph: An Assessment of the âJay-darâ in Neuropsychologists
-
A social network analysis of substance use among immigrant adolescents in six European cities
-
Alcohol, tobacco and cannabis use: Do students with mild-intellectual disability mimic students in the general population?
-
Persistent cannabis dependence and alcohol dependence represent risks for midlife economic and social problems: A longitudinal cohort study
-
Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA
-
Modelling possible causality in the associations between unemployment, cannabis use, and alcohol misuse
-
Cannabis use and dating violence among college students: A call for research
-
Social factors in marijuana use for medical and recreational purposes
-
Alternate policing strategies: Cost-effectiveness of cautioning for cannabis offences
SOCIAL MEDIA/INTERNET (25)
-
The identification of rimonabant polymorphs, sibutramine and analogues of both in counterfeit Acomplia bought on the internet
-
Internet Highs-Seizures After Consumption of Synthetic Cannabinoids Purchased Online
-
Effectiveness of a self-guided web-based cannabis treatment program: randomized controlled trial
-
UR-144 in products sold via the Internet: Identification of related compounds and characterization of pyrolysis products
-
An Internet survey of marijuana and hot shower use in adults with cyclic vomiting syndrome (CVS)
-
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users
-
Frequent electronic media communication with friends is associated with higher adolescent substance use
-
Prevalence of Marijuana-Related Traffic on Twitter, 2012-2013: A Content Analysis
-
Twitter Chatter about Marijuana
-
Cannabis Mobile Apps: A Content Analysis
-
Using Web searches to track interest in synthetic cannabinoids (aka âherbal incenseâ)
-
âTime for dabsâ: Analyzing Twitter data on marijuana concentrates across the US.
-
Displays of dabbing marijuana extracts on YouTube
-
Tracking Dabbing Using Search Query Surveillance: A Case Study in the United States
-
Ecological Momentary Assessment and Smartphone Application Intervention in Adolescents with Substance Use and Comorbid Severe Psychiatric Disorders: Study Protocol
-
âWhen âBadâ is âGood'â: Identifying Personal Communication and Sentiment in Drug Related Tweets.
-
Marijuana: Views on Its Medical Use Recorded at the Slovak Social Network
-
âI Use Weed for My ADHDâ: A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD
-
From âherbal highsâ to the âheroin of cannabisâ: Exploring the evolving discourse on synthetic cannabinoid use in a Norwegian Internet drug forum
-
Marijuana-Related Posts on Instagram
-
A content analysis of tweets about high-potency marijuana
-
Assessing the Validity of Online Drug Forums as a Source for Estimating Demographic and Temporal Trends in Drug Use
-
Exploring Marijuana Advertising on Weedmaps, a Popular Online Directory
-
Buying drugs on a Darknet market: A better deal? Studying the online illicit drug market through the analysis of digital, physical and chemical data
-
Examination of YouTube videos related to synthetic cannabinoids
SPASTICITY (73)
-
New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids
-
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis
-
Role of cannabinoids in the treatment of pain and (painful) spasticity
-
Dronabinol for the treatment of unspecific pain, restlessness and spasticity in neuropaediatrics
-
Emerging treatment options for spasticity in multiple sclerosis, clinical utility of cannabinoids
-
Role of Cannabinoids in Multiple Sclerosis
-
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®)), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
-
THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis
-
Cannabinoids in children
-
FROM GHENNAB TO CANNABIS: HOPES TO FIND A CURE FOR MULTIPLE SCLEROSIS ARE FLOURISHING
-
The Therapeutic Potential of Cannabis and Cannabinoids
-
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)
-
Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis
-
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
-
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity
-
Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity
-
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis
-
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis
-
What place for cannabis extract in MS?
-
Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids
-
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis
-
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis
-
Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists
-
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain
-
Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report
-
A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost-effectiveness in Germany
-
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis
-
Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice
-
Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience
-
THC:CBD Spray and MS Spasticity Symptoms: Data from Latest Studies
-
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways
-
Complementary and alternative medical therapies in multiple sclerosis-the american academy of neurology guidelines: a commentary
-
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosisrelated spasticity
-
Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice â Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity
-
Delta-9-Tetrahydrocannabinol/Cannabidiol (Sativex®): A Review of Its Use in Patients with Moderate to Severe Spasticity Due to Multiple Sclerosis
-
Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice
-
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis
-
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users
-
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis
-
There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis
-
âDisease Modifying Nutricalsâ for multiple sclerosis
-
Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Cortico-spinal Modulation
-
Cannabinoids for Medical Use A Systematic Review and Meta-analysis
-
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders
-
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
-
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review
-
Medical Marijuana: Is the Cart Before the Horse?
-
A sativex-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis
-
Clinical perspectives on medical marijuana (cannabis) for neurologic disorders
-
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis
-
Drug-resistant MS spasticity treatment with Sativex® add-on and driving ability
-
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials
-
Modulatory effects by CB1 receptors on rat spinal locomotor networks after sustained application of agonists or antagonists
-
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children
-
Cannabinoids for the Treatment of Movement Disorders
-
Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis
-
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence
-
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis
-
THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms
-
THC:CBD in Daily Practice: Available Data from UK, Germany and Spain
-
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity
-
Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis?
-
The use of medical-grade cannabis in patients non-responders to Nabiximols
-
A cost-effectiveness model for the use of a cannabis-derived oromucosal spray for the treatment of spasticity in multiple sclerosis
-
Nabilone for the Management of Pain
-
The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity
-
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity
-
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis
-
Role of nurses in the managements of symptoms associated with spasticity in patients with multiple sclerosis
-
Pros and cons of medical cannabis use by people with chronic brain disorders
-
Medical Marijuana: Just the Beginning of a Long, Strange Trip?
-
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis
-
Cannabis use in persons with traumatic spinal cord injury in Denmark
SPINAL CORD INJURY (53)
-
Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain
-
R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids
-
A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury
-
Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study
-
Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain
-
The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury
-
Cannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases
-
Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury
-
Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain
-
Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury
-
Targetting CB1 Cannabinoid Receptor for Neuroprotetion in Spinal Cord Injury
-
Spinal Cord Injuries Induce Changes of CB1 Cannabinoid Receptor and C-C Chemokine Expression in Brain Areas Underlying Circuitry of Chronic Pain Conditions
-
Cannabidiol-treated Rats Exhibited Higher Motor Score After Cryogenic Spinal Cord Injury
-
Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury
-
EFFECT OF AQUATIC EXTRACT OFCANNABIS SATIVA LEAVES ON DEGENERATION OF ALPHA MOTONEURONS IN SPINAL CORD AFTER SCIATIC NERVE COMPRESSION IN RATS
-
Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery
-
A Role for the Cannabinoid 1 Receptor in Neuronal Differentiation of Adult Spinal Cord Progenitors in vitro is Revealed through Pharmacological Inhibition and Genetic Deletion
-
A cell population that strongly expresses the CB1 cannabinoid receptor in the ependyma of the rat spinal cord
-
The interaction between intrathecal administration of low doses of palmitoylethanolamide and AM251 in formalin-induced pain related behavior and spinal cord IL1-β expression in rats
-
Specific inhibition of the JNK pathway promotes locomotor recovery and neuro-protection after mouse spinal cord injury
-
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
-
Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats
-
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
-
Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury
-
Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries
-
Medicinal Cannabis and Painful Sensory Neuropathy
-
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator
-
Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats
-
Heterogeneous presynaptic distribution of monoacylglycerol lipase, a multipotent regulator of nociceptive circuits in the mouse spinal cord
-
Involvement of cannabinoid receptors in peripheral and spinal morphine analgesia
-
Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation
-
Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration
-
Effects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury pain
-
Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury
-
Report on Medical Cannabis Research, What the Science Says
-
Descending modulation of pain: the GABA disinhibition hypothesis of analgesia
-
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain?
-
PROGRESS REPORT Compassionate Use of Medical Cannabis Pilot Program Act July 1,
-
Spinal RGS4 inhibition effectively attenuates neuropathic hyperalgesia and restores cannabinoid receptor type 1 signaling
-
Spinal RGS4 inhibition effectively attenuates neuropathic hyperalgesia and restores cannabinoid receptor type 1 signaling
-
Cannabinoids to treat spinal cord injury
-
CB 1Cannabinoid Receptor Agonist Inhibits Matrix Metalloproteinase Activity in Spinal Cord Injury: A Possible Mechanism of Improved Recovery
-
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution
-
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
-
A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis. (link to PDF â
-
Effect of cannabinoids on CGRP release in the isolated rat lumbar spinal cord
-
The molecular mechanism and effect of cannabinoid-2 receptor agonist on the bloodspinal cord barrier permeability induced by ischemia-reperfusion injury
-
An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain from Spinal Cord Injury and Disease
-
A study of cannabinoid-1 receptors during the early phase of excitotoxic damage to rat spinal locomotor networks in vitro
-
Type-2 cannabinoid receptors in neurodegeneration
-
Examining the Relationship Between Traumatic Brain Injury and Substance Use Outcomes in the Canadian Population
-
Activation of cannabinoid CB1 receptor contributes to suppression of spinal nociceptive transmission and inhibition of mechanical hypersensitivity by Aβ-fiber stimulation
-
Cannabis use in persons with traumatic spinal cord injury in Denmark
SPINOCEREBELLAR ATAXIA/SCA (4)
-
Disruption of metabotropic glutamate receptor signalling is a major defect at cerebellar parallel fibre-Purkinje cell synapses in staggerer mutant mice
-
Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias
-
Endocannabinoid-hydrolysing enzymes in the post-mortem cerebellum of humans affected by hereditary autosomal dominant ataxias
-
Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3
SPLEEN (17)
-
Regulatory effect of cannabinoid receptor agonist on chemokine-induced lymphocyte chemotaxis
-
Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone
-
Differential Modulation by Delta(9)-Tetrahydrocannabinol (â (9)-THC) of CD40 Ligand (CD40L) Expression in Activated Mouse Splenic CD4(+) T cells
-
Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120
-
Cannabinoid Receptor 2 (CB2) Plays a Role in the Generation of Germinal Center and Memory B Cells, but Not in the Production of Antigen-Specific IgG and IgM, in Response to T-dependent Antigens
-
Characterization of cannabinoid receptor ligands in tissues natively expressing cannabinoid CB2 receptors
-
Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice
-
Whole-Body Biodistribution and Radiation Dosimetry of the Cannabinoid Type 2 Receptor Ligand [11C]-NE40 in Healthy Subjects
-
Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue
-
4â²-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation
-
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells
-
Expression Analysis of CB2-GFP BAC Transgenic Mice
-
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis
-
Lipopolysaccharide Suppresses Carboxylesterase 2g Activity and 2-Arachidonylglycerol Hydrolysis: A Possible Mechanism to Regulate Inflammation
-
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis
-
Effects of Adolescent Intermittent Alcohol Exposure on the Expression of Endocannabinoid Signaling-Related Proteins in the Spleen of Young Adult Rats
-
Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors
SPORTS (10)
-
Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls
-
High-performance sport, marijuana, and cannabimimetics
-
Prevalence of Synthetic Cannabinoids in U.S. Athletes: Initial Findings
-
Why should Cannabis be Considered Doping in Sports?
-
Hair-based rapid analyses for multiple drugs in forensics and doping: application of dynamic multiple reaction monitoring with LC-MS/MS
-
UPLC-ESI-Q-TOF-MSE identification of urinary metabolites of the emerging sport nutrition supplement methoxyisoflavone in human subjects
-
Annual banned-substance review: analytical approaches in human sports drug testing
-
Cannabis and Exercise Science: A Commentary on Existing Studies and Suggestions for Future Directions
-
Prevalence and Correlates of Any and Frequent Synthetic Cannabinoid Use in a Representative Sample of High School Students
-
Synthetic Cannabinoid Use and Descriptive Norms among Collegiate Student-Athletes
STEM CELLS (32)
-
Endocannabinoids Are Expressed in Bone Marrow Stromal Niches and Play a Role in Interactions of Hematopoietic Stem and Progenitor Cells with the Bone Marrow Microenvironment
-
Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking
-
Pleiotropic effects of prostaglandin E(2) in hematopoiesis, prostaglandin E(2) and other eicosanoids regulate hematopoietic stem and progenitor cell function
-
Endocannabinoids via CBâ receptors act as neurogenic niche cues during cortical development
-
G protein-coupled receptor crosstalk and signaling in hematopoietic stem and progenitor cells
-
Type-1 (CB(1)) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neural Stem Cells
-
The Cannabinoid Receptor Type 2 as Mediator of Mesenchymal Stromal Cell Immunosuppressive Properties
-
The cannabinoid receptor type 1 is essential for mesenchymal stem cell survival and differentiation: implications for bone health
-
The effect cannabichromene on adult neural stem/progenitor cells
-
Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation
-
Impact of omega-6 polyunsaturated fatty acid supplementation and γ-aminobutyric acid on astrogliogenesis through the endocannabinoid system
-
Modulation of subventricular zone oligodendrogenesis: a role for hemopressin?
-
Effects of cannabinoid receptor type 2 on endogenous myocardial regeneration by activating cardiac progenitor cells in mouse infarcted heart.
-
Activation of Cannabinoid Receptor 2 Enhances Osteogenic Differentiation of Bone Marrow Derived Mesenchymal Stem Cells
-
A cannabinoid receptor agonist N-arachidonoyl dopamine inhibits adipocyte differentiation in human mesenchymal stem cells
-
A Basal Tone of 2-Arachidonoylglycerol Contributes to Early Oligodendrocyte Progenitor Proliferation by Activating Phosphatidylinositol 3-Kinase (PI3K)/AKT and the Mammalian Target of Rapamycin (MTOR) Pathways
-
Inhibition of FAAH confers increased stem cell migration via PPARα
-
CB1 cannabinoid receptor enrichment in the ependymal region of the adult human spinal cord
-
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study
-
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study
-
Cannabinoid Receptor-2 Regulates Embryonic Hematopoietic Stem Cell Development via PGE2 and P-selectin Activity
-
Cannabinoid Receptorâ2 Regulates Embryonic Hematopoietic Stem Cell Development via Prostaglandin E2 and PâSelectin Activity
-
Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2
-
Cannabinoid receptor 2 modulates susceptibility to experimental cerebral malaria through a CCL17-dependent mechanism
-
Cannabidiol Modulates the Expression of Alzheimerâs Disease-Related Genes in Mesenchymal Stem Cells
-
Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells
-
Cannabinoid Receptor 1 Mediates Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury.
-
Distinctive effects of eicosapentaenoic and docosahexaenoic acids in regulating neural stem cell fate are mediated via endocannabinoid signalling pathways.
-
Regulated endosomal trafficking of Diacylglycerol lipase alpha (DAGLα) generates distinct cellular pools, implications for endocannabinoid signaling
-
Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked with Amyotrophic Lateral Sclerosis
-
Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo
-
Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells
STIFF-PERSON SYNDROME/HYPEREKPLEXIA DISEASE (2)
STORAGE of CANNABIS (11)
-
The stability of cannabis and its preparations on storage 1976
-
The decomposition of acidic and neutral cannabinoids in organic solvents 1977
-
Constituents of Cannabis sativa L. XIII: Stability of dosage form prepared by impregnating synthetic (â)-delta 9-trans-tetrahydrocannabinol on placebo Cannabis plant material 1978
-
Stability of Cannabis sativa L. samples and their extracts, on prolonged storage in Delhi 1978
-
Stability of Cannabinoids in Dried Samples of Cannabis Dating from Around 1896-1905
-
Temperature and Moisture Content for Storage Maintenance of Germination Capacity of Seeds of Industrial Hemp, Marijuana, and Ditchweed Forms of Cannabis sativa.
-
Determination of the relative percentage distribution of THCA and Î9-THC in herbal cannabis seized in Austria â Impact of different storage temperatures on stability
-
Storage and disposal of medical cannabis among patients with cancer: Assessing the risk of diversion and unintentional digestion
-
Preparation and Distribution of Cannabis and Cannabis-Derived Dosage Formulations for Investigational and Therapeutic Use in the United States
-
Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method
-
Stability of Tetrahydrocannabinol and Cannabidiol in Prepared Quality Control Medible Brownies
STRAIN INFORMATION (15)
-
Investigations into the Hypothesis of Transgenic Cannabis
-
Analysis of Genetic Diversity using SSR Markers and Cannabinoid Contents in Different Varieties of Cannabis sativa L.
-
CYTOLOGICAL STUDIES OF CANNABIS SATIVA IN SHIMLA HILLS OF HIMACHAL PRADESH
-
Hemp Biology â Industrial Hemp vs. Marijuana
-
Cannabis â from cultivar to chemovar
-
Extraction of high quality DNA from seized moroccan cannabis resin (hashish)
-
From 32 ounces to zero: a medical geographic study of dispensing a cultivated batch of âplumâ cannabis flowers to medical marijuana patients in Washington State
-
Cold acclimation induces distinctive changes in the chromatin state and transcript levels of COR genes in Cannabis sativa varieties with contrasting cold acclimation capacities
-
Characterisation of cannabinoid composition in a diverse Cannabis sativa L. germplasm collection (link to PDF â
-
Effect of induced polyploidy on some biochemical parameters in Cannabis sativa L.
-
Size matters: evolution of large drug-secreting resin glands in elite pharmaceutical strains of Cannabis sativa (marijuana)
-
Variability in Seed Traits in a Collection of Cannabis sativa L. Genotypes
-
A Belated Green Revolution for Cannabis: Virtual Genetic Resources to Fast-Track Cultivar Development.
-
Pain, Cannabis Species, and Cannabis Use Disorders.
-
In vitro Antimicrobial and Antioxidant Activity of Extracts from Six Chemotypes of Medicinal Cannabis
STRESS (158)
-
Endogenous cannabinoid signaling is essential for stress adaptation
-
Motion Sickness, Stress and the Endocannabinoid System
-
Maternal Dietary Fat Determines Metabolic Profile and the Magnitude of Endo-cannabinoid Inhibition of the Stress Response in Neonatal Rat Offspring
-
Deficiency in Endocannabinoid Signaling in the Nucleus Accumbens Induced by Chronic Unpredictable Stress
-
Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress
-
Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior, and adaptations to stress
-
Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress
-
Alterations in Corticolimbic Dendritic Morphology and Emotional Behavior in Cannabinoid CB1 ReceptorâDeficient Mice Parallel the Effects of Chronic Stress
-
Endocannabinoids and the cardiovascular response to stress
-
Effects of exercise stress on the endocannabinoid system in humans under field conditions
-
Cannabinoid receptor expression and phosphorylation are differentially regulated between male and female cerebellum and brain stem after repeated stress: Implication for PTSD and drug abuse
-
Activation of Type 5 Metabotropic Glutamate Receptors and Diacylglycerol Lipase-α Initiates 2-Arachidonoylglycerol Formation and Endocannabinoid-Mediated Analgesia
-
Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice
-
Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity
-
Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans
-
Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO
-
Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress
-
Neural Substrates Underlying Interactions between Appetite Stress and Reward
-
Cannabinoid modulation of midbrain urocortin 1 neurones during acute and chronic stress
-
Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat
-
Cannabinoid CB(1) receptor in the modulation of stress coping behaviour in mice: the role of serotonin and different forebrain neuronal subpopulations
-
Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat
-
Age of Stress Exposure Modulates the Immediate and Sustained Effects of Repeated Stress on
-
Ventral Tegmental Area Cannabinoid Type-1 Receptors Control Voluntary Exercise Performance
-
Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors
-
Translational evidence for the involvement of the endocannabinoid system in stress related psychiatric illnesses
-
Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory
-
Cannabinoid modulation of chronic mild stress-induced selective enhancement of trace fear conditioning in adolescent rats
-
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
-
The effects of anandamide signaling enhanced by the FAAH inhibitor URB597 on coping styles in rats
-
Effects of Acute Stress on Cardiac Endocannabinoids, Lipogenesis, and Inflammation in Rats
-
Cannabinoid Receptor Activation Prevents the Effects of Chronic Mild Stress on Emotional Learning and LTP in a Rat Model of Depression
-
Endocannabinoid Signaling in Hypothalamic-Pituitary-Adrenocortical Axis Recovery Following Stress: Effects of Indirect Agonists and Comparison of Male and Female Mice
-
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks
-
Amygdala FAAH and anandamide: mediating protection and recovery from stress
-
Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit
-
Distress, Coping, and Drug Law Enforcement in a Series of Patients Using Medical Cannabis
-
Emotional, endocrine and brain anandamide response to social challenge in infant male rats
-
Cannabinoids and glucocorticoids modulate emotional memory after stress
-
Effects of the fatty acid amide hydrolase inhibitor URB597 on coping behavior under challenging conditions in mice
-
Cannabidiol administration into the bed nucleus of the stria terminalis alters cardiovascular responses induced by acute restraint stress through 5-HTâA receptor
-
Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation
-
Effects of chaiyuwendan decoction on endocannabinoids levels in adipose tissue of rats with chronic stress-induced depression
-
Polymorphic expression of CYP2C19 and CYP2D6 in the developing and adult human brain causing variability in cognition, risk for depression and suicide: the search for the endogenous substrates
-
Cannabis use and anxiety: is stress the missing piece of the puzzle?
-
Chronic stimulation of the tone of endogenous anandamide reduces cue â and stress induced relapse in rats
-
Therapeutic Potential of Inhibitors of Endocannabinoid Degradation for the Treatment of Stress-Related Hyperalgesia in an Animal Model of Chronic Pain
-
Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic Brain Injury: Implications from Animal Studies
-
Cannabinoid Modulation of Amygdala Subregion Functional Connectivity to Social Signals of Threat
-
Multiple Mechanistically Distinct Modes of Endocannabinoid Mobilization at Central Amygdala Glutamatergic Synapses
-
Regulatory role of the Cannabinoid-2 receptor in stress-induced neuroinflammation in mice
-
Relationships between serotonergic and cannabinoid system in depressive-like behavior: a PET study with [11C]-DASB
-
Stress regulates endocannabinoid-CB1 receptor signaling
-
Epigenetic Regulation of Genes that Modulate Chronic Stress-induced Visceral Pain in the Peripheral Nervous System
-
Endocannabinoid Signaling within the Basolateral Amygdala Integrates Multiple Stress Hormone Effects on Memory Consolidation.
-
Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion
-
Endocannabinoid-mediated retrograde modulation of synaptic transmission
-
Endocannabinoids and energy homeostasis: An update
-
Cannabinoids and schizophrenia: therapeutic prospects
-
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis
-
Strain- and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats
-
Cannabinoid receptor CB2 prevents development of heart failure in a murine model of pressure overload
-
Cannabinoids, endocannabinoids and stress
-
Impact of Stress on Prefrontal Glutamatergic, Monoaminergic and Cannabinoid Systems
-
MicroRNA-665 is involved in the regulation of the expression of the cardioprotective cannabinoid receptor CB2 in patients with severe heart failure
-
Role of the basolateral amygdala in mediating the effects of the fatty acid amide hydrolase inhibitor URB597 on HPA axis response to stress
-
Consequences of early life stress on the expression of endocannabinoid-related genes in the rat brain
-
Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity
-
Increased contextual fear conditioning in iNOS knockout mice: additional evidence for the involvement of nitric oxide in stress-related disorders and contribution of the endocannabinoid system
-
High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity
-
Targeting the endocannabinoid system to treat anxiety-related disorders
-
Cannabisâthe Israeli perspective
-
Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety
-
Developmental regulation of fear learning and anxiety behavior by endocannabinoids
-
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes
-
Chronic Stress Induces Anxiety via an Amygdalar Intracellular Cascade that Impairs Endocannabinoid Signaling
-
The endocannabinoid system in guarding against fear, anxiety and stress
-
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally-restricted manner
-
Training-Associated Emotional Arousal Shapes Endocannabinoid Modulation of Spatial Memory Retrieval in Rats
-
Mechanisms of stress in the brain
-
Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis.
-
Diet-induced changes in n-3 and n-6 derived endocannabinoids and reductions in headache pain and psychological distress
-
Neurobiological Interactions Between Stress and the Endocannabinoid System
-
CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats
-
Endocannabinoid signaling in the stress response of male and female songbirds
-
Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stress
-
Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression
-
Acute administration of a cannabinoid CB1 receptor antagonist impairs stress-induced antinociception in fish
-
Cannabinoids & Stress: Impact of HU-210 on behavioral tests of anxiety in acutely stressed mice
-
Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences
-
Interaction of cannabinoid receptor 2 and social environment modulates chronic alcohol consumption
-
Antidepressant-like Effects of Oleoylethanolamide in a Mouse Model of Chronic Unpredictable Mild Stress
-
Repeated forced swim stress differentially affects formalin-evoked nociceptive behaviour and the endocannabinoid system in stress normo-responsive and stress hyper-responsive rat strains
-
Evidence against a critical role of CB1 receptors in adaptation of the hypothalamic pituitary-adrenal axis and other consequences of daily repeated stress
-
Stress-related synaptic plasticity in the hypothalamus
-
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder
-
Cannabinoids and Glucocorticoids in the Basolateral Amygdala Modulate Hippocampal Accumbens Plasticity after Stress
-
Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats
-
Abnormalities in neuroendocrine stress response in psychosis: the role of endo-cannabinoids
-
Antidepressant-like activity and cardioprotective effects of fatty acid amide hydrolase inhibitor URB694 in socially stressed Wistar Kyoto rats
-
Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathways
-
Inhibition of anandamide hydrolysis dampens the neuroendocrine response to stress in neonatal rats subjected to suboptimal rearing conditions
-
Maternal separation and early stress cause long-lasting effects on dopaminergic and endocannabinergic systems and alters dendritic morphology in the nucleus accumbens and frontal cortex in rats
-
Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice
-
Endocannabinoid Regulation of Neuroendocrine Systems
-
The Role of the Brainâs Endocannabinoid System in Pain and Its Modulation by Stress
-
Stress and memory: A selective review on recent developments in the understanding of stress hormone effects on memory and their clinical relevance
-
Endocannabinoid signaling integrates multiple stress hormone effects on memory
-
Being the Victim of Violence during a Date predicts Next-Day Cannabis Use among Female College Students
-
Mediating processes between stress and problematic marijuana use
-
The maternal deprivation animal model revisited
-
Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands
-
2-arachidonoylglycerol signaling impairs short-term fear extinction
-
Cannabis use among Navy personnel in Sri Lanka: a cross sectional study
-
Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses
-
Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder
-
Cyclooxygenase-2 inhibition reduces stress-induced affective pathology
-
Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoidmediated disinhibition of dopaminergic neurons
-
Endocannabinoid-Mediated Plasticity in Nucleus Accumbens Controls Vulnerability to Anxiety after Social Defeat Stress
-
Endocannabinoid signaling in social functioning: an RDoC perspective
-
Cannabis craving in response to laboratory-induced social stress among racially diverse cannabis users: The impact of social anxiety disorder
-
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood
-
Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans
-
Bidirectional Effects of Cannabidiol on Contextual Fear Memory Extinction
-
Getting into the weed: the role of the endocannabinoid system in the brain-gut axis. (link to full via ELSEVIER â
-
Role of hypothalamic cannabinoid receptors in post-stroke depression in rats
-
Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors
-
Chronic alcohol exposure disrupts CB1 regulation of GABAergic transmission in the rat basolateral amygdala
-
Social defeat leads to changes in the endocannabinoid system, an overexpression of calreticulin and motor impairment in mice
-
Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function
-
The effects anandamide signaling in the prelimbic cortex and basolateral amygdala on coping with environmental stimuli in rats
-
Endocannabinoids in Cerebrovascular Regulation
-
Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid/CB1 signaling in the mouse periaqueductal gray.
-
Sex differences in hippocampal response to endocannabinoids after exposure to severe stress.
-
Effects of the antipsychotic paliperidone on stress-induced changes in the endocannabinoid system in rat prefrontal cortex.
-
Childhood Maltreatment in the Migraine Patient.
-
Activation of cannabinoid CB1 receptors in the ventral hippocampus improved stressinduced amnesia in rat.
-
Exercise as an adjunctive treatment for cannabis use disorder.
-
Docosahexaenoic acid attenuates in endocannabinoid synthesis in RAW 264.7 macrophages activated with benzo(a)pyrene and lipopolysaccharide.
-
Just add water: cannabinoid discrimination in a water T-maze with FAAH(-/-) and (+/+) mice.
-
Acute effects of cannabis on breath-holding duration.
-
Involvement of endocannabinoid neurotransmission in the bed nucleus of stria terminalis in cardiovascular responses to acute restraint stress in rats.
-
Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses.
-
Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala.
-
Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophrenia.
-
Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation.
-
Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention.
-
Marijuana use in adults admitted to a Canadian epilepsy monitoring unit.
-
FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence.
-
Chronic stress leads to epigenetic dysregulation of neuropeptide-Y and cannabinoid CB1 receptor in the mouse cingulate cortex.
-
Variants in the CNR1 gene predispose to headache with nausea in the presence of life stress.
-
Older marijuana users: Life stressors and perceived social support.
-
Anxiety Sensitivity and Distress Intolerance as Predictors of Cannabis Dependence Symptoms, Problems, and Craving: The Mediating Role of Coping Motives.
-
Regulation of fear extinction by long-term depression: the roles of endocannabinoids and brain derived neurotrophic factor.
-
Cannabimimetic phytochemicals in the diet â an evolutionary link to food selection and metabolic stress adaptation?
-
Sex-dependent influence of chronic mild stress (CMS) on voluntary alcohol consumption, study of neurobiological consequences.
-
Identification of an endocannabinoid system in the rat pars tuberalis-a possible interface in the hypothalamic-pituitary-adrenal system?
-
Endocannabinoid Signaling and the Hypothalamic-Pituitary-Adrenal Axis.
STROKE (97)
-
The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia
-
The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration
-
The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration.
-
Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke
-
Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment
-
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic ischemic brain damage in mice is mediated by CB(2) and adenosine receptors
-
Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia ischemia in newborn pigs
-
Targeting the Endocannabinod System to Limit Myocardial and Cerebral Ischemic and Reperfusion Injury
-
Cannabinoid receptor type 2 activation yields delayed tolerance to focal cerebral ischemia
-
Residual effects of focal brain ischaemia upon cannabinoid CB(1) receptor density and functionality in female rats
-
Medical cannabis: the opportunity versus the temptation
-
Contribution of Hypothermia and CB(1) Receptor Activation to Protective Effects of TAK-937, a Cannabinoid Receptor Agonist, in Rat Transient MCAO Model
-
Update on the role of cannabinoid receptors after ischemic stroke
-
Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection
-
Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke
-
Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies
-
Neuroprotection by inhibiting the c-Jun N-terminal kinase pathway after cerebral ischemia occurs independently of interleukin-6 and keratinocyte-derived chemokine (KC/CXCL1) secretion
-
WIN55,212-2 protects oligodendrocyte precursor cells in stroke penumbra following permanent focal cerebral ischemia in rats
-
WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve remyelination through regulation of the phosphorylation level of the ERK 1/2 via cannabinoid receptor 1 after stroke-induced demyelination
-
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
-
Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates
-
The Cannabinoid WIN 55212-2 Mitigates Apoptosis and Mitochondrial Dysfunction After Hypoxia Ischemia
-
Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption in focal cerebral ischemia in rats
-
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke
-
Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α
-
Cannabinoid Receptor Subtypes 1 and 2 Mediate Long-Lasting Neuroprotection and Improve Motor Behaviour Deficits After Transient Focal Cerebral Ischemia
-
A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury
-
Molecular targets underlying SUMO-mediated neuroprotection in brain ischemia
-
Is the cardiovascular system a therapeutic target for cannabidiol?
-
Drug-Induced Hypothermia in Stroke Models: Does it Always Protect?
-
Activation of Cannabinoid CB2 Receptor-Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury
-
Ischemic stroke after use of the synthetic marijuana âspiceâ
-
The neuroprotective effects of cocoa flavanol and its influence on cognitive performance
-
Does smoking marijuana cause stroke?
-
Nicotine-Induced Neuroprotection Against Ischemic Injury Involves Activation of Endocannabinoid System in Rats
-
Activation of STAT3 is involved in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptors in rats
-
Acupuncture therapy for stroke patients
-
Effect of cannabinoid CB2 receptor agonism on learning and memory in a mouse model of photothrombosis
-
Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: Therapeutic time window, combination with t-PA and efficacy in aged rats
-
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review
-
Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegeneration
-
Synthetic Cannabis and Acute Ischemic Stroke
-
Unique effects of compounds active at both cannabinoid and serotonin receptors during stroke
-
âLegal highâ associated Wallenberg syndrome
-
Cannabinoids: well-suited candidates for the treatment of perinatal brain injury
-
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
-
Hypoximimetic activity of N-acyl-dopamines. N-arachidonoyl-dopamine stabilizes HIF-1α protein through a SIAH2-dependent pathway
-
Cannabinoids in experimental stroke: a systematic review and meta-analysis
-
The cannabinoid CB2 receptor agonist GW405833 does not ameliorate brain damage induced by hypoxia-ischemia in rats
-
Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury
-
Severe rhabdomyolysis and intracranial hemorrhage associated with synthetic cannabinoid: a case report
-
A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid
-
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation
-
Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice
-
Magnolol protects neurons against ischemia injury via the downregulation of p38/MAPK, CHOP and nitrotyrosine
-
Glycogen synthase kinase-3β is involved in electroacupuncture pretreatment via the cannabinoid CB1 receptor in ischemic stroke
-
Endocannabinoids modulate human blood-brain barrier permeability in vitro
-
Involvement of GluR2 up-regulation in neuroprotection by electro-acupuncture pretreatment via cannabinoid CB1 receptor in mice
-
Time-Dependent Protection of CB2 Receptor Agonist in Stroke
-
Non-Selective Cannabinoid Receptor Antagonists, Hinokiresinols Reduce Infiltration of Microglia/Macrophages into Ischemic Brain Lesions in Rat via Modulating 2-Arachidonolyglycerol-Induced Migration and Mitochondrial Activity
-
Synthetic cannabinoids: the multi-organ failure and metabolic derangements associated with getting high
-
Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions
-
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Pre-clinical Models to Clinical Applications
-
A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice
-
A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice
-
Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice
-
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling
-
Protective effect of paeoniflorin on the hippocampus in rats with cerebral ischemia reperfusion through activating cannabinoid receptor 2
-
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe?
-
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution
-
Cannabis, Cannabinoids, and Cerebral Metabolism: Potential Applications in Stroke and Disorders of the Central Nervous System
-
Neuroprotective mechanisms of cannabinoids in brain ischemia and neurodegenerative disorders
-
Effects of Chronic Alcohol Exposure on the Modulation of Ischemia-Induced Glutamate Release via Cannabinoid Receptors in the Dorsal Hippocampus
-
Endocannabinoids and the Cardiovascular System in Health and Disease
-
A pathophysiological role of TRPV1 in ischemic injury after transient focal cerebral ischemia in mice.
-
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
-
Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons.
-
Role of hypothalamic cannabinoid receptors in post-stroke depression in rats
-
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation
-
Prior Cannabis Use Is Associated with Outcome after Intracerebral Hemorrhage
-
Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions
-
Endocannabinoids in Cerebrovascular Regulation
-
Arachidonyl-2-Chloroethylamide Alleviates Cerebral Ischemia Injury Through Glycogen Synthase Kinase-3β-Mediated Mitochondrial Biogenesis and Functional Improvement
-
Sevoflurane Prevents Stroke-induced Depressive and Anxiety Behaviors by Promoting Cannabinoid Receptor Subtype I-dependent Interaction Between β-Arrestin 2 and ERK1/2 in the Rat Hippocampus.
-
Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias.
-
Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting Neuron from Cerebral Ischemia.
-
Pharmacological hypothermia: a potential for future stroke therapy?
-
Ischemic Stroke, Excitatory Amino Acids Toxicity and the Adjustment of Acupuncture Intervention
-
The CB1 antagonist, SR141716A, is protective in permanent photothrombotic cerebral ischemia
-
Expression of the Endocannabinoid Receptor 1 in Human Stroke: An Autoptic Study.
-
Repeated Thrombosis After Synthetic Cannabinoid Use.
-
Acute Effects of Synthetic Cannabinoids: Update 2015.
-
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia.
-
Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke.
-
URB597 improves cognitive impairment induced by chronic cerebral hypoperfusion by inhibiting mTOR-dependent autophagy.
-
Cannabis, Tobacco, Alcohol Use, and the Risk of Early Stroke: A Population-Based Cohort Study of 45 000 Swedish Men.
-
Involvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion.
SUICIDE (16)
-
Mixed mood disorder
-
Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides
-
Personalized medicine can pave the way for the safe use of CBâ receptor antagonists
-
High on Life? Medical Marijuana Laws and Suicide
-
Suicidal ideation and self-harm following K2 use
-
Does the legalization of medical marijuana increase completed suicide?
-
Polymorphic expression of CYP2C19 and CYP2D6 in the developing and adult human brain causing variability in cognition, risk for depression and suicide: the search for the endogenous substrates
-
Medical Marijuana Laws and Suicides by Gender and Age
-
Cannabis use and suicidal ideations in high-school students
-
Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects
-
A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients
-
Endocannabinoids and Mental Disorders
-
Cannabis for posttraumatic stress disorder: A neurobiological approach to treatment
-
Dose of Reality: The Effect of State Marijuana Legalizations
-
Suicide attempt with a mix of synthetic cannabinoids and synthetic cathinones: Case report of non-fatal intoxication with AB-CHMINACA, AB-FUBINACA, alpha-PHP, alpha-PVP and 4-CMC.
-
A multicenter retrospective survey of poisoning after consumption of products containing novel psychoactive substances from
SYSTEMIC MASTOCYTOSIS (1)
SYSTEMIC SCLEROSIS (7)
-
Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis
-
Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis
-
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system
-
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis
-
Pathogenesis of Systemic Sclerosis
-
Can Cannabinoids Modulate Fibrotic Progression in Systemic Sclerosis?
-
Medical Cannabis â another piece in the mosaic of autoimmunity?
